Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral Agents”

1,185 trials

Showing 20 of 1,185 results

Testing effectiveness (Phase 2)Ended earlyNCT00102778
What this trial is testing

GW873140 In Combination With Kaletra In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 175
Not applicableNot Yet RecruitingNCT06432855
What this trial is testing

Genetic Determinants of the Antiviral Immune Response in Oceanian Populations

Who this might be right for
Virus
Institut Pasteur 220
Not applicableEnded earlyNCT03483987
What this trial is testing

Re-treatment of HCV Following DAA Failure

Who this might be right for
Chronic Hepatitis C
Sanjay Gandhi Postgraduate Institute of Medical Sciences 18
Not applicableStudy completedNCT04719338
What this trial is testing

Occult HCV Infection After DAAD Treatment in Haemodialysis Patients

Who this might be right for
Hepatitis C
Alexandria University 30
Early research (Phase 1)Study completedNCT00000984
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Very early researchStudy completedNCT03188276
What this trial is testing

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 52
Post-approval studies (Phase 4)Study completedNCT01439776
What this trial is testing

Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Hanyang University 180
Testing effectiveness (Phase 2)Study completedNCT00004584
What this trial is testing

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Not applicableNot Yet RecruitingNCT07120750
What this trial is testing

Post-Radical Treatment Antiviral Strategies in HBV-Related Liver Cancer: Impact on Tumor Prognosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Chronic Hepatitis B
Shenzhen Third People's Hospital 332
Early research (Phase 1)Study completedNCT00781976
What this trial is testing

Antiviral Activity of AZD7295 in HCV Carriers

Who this might be right for
Hepatitis C
Arrow Therapeutics 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06338826
What this trial is testing

Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses

Who this might be right for
HIV InfectionsHBV Coinfection
ANRS, Emerging Infectious Diseases 140
Not applicableActive Not RecruitingNCT05388474
What this trial is testing

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Who this might be right for
HIV InfectionsMulti-Antiviral Resistance
Theratechnologies 168
Early research (Phase 1)Study completedNCT00000810
What this trial is testing

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Not applicableStudy completedNCT03348059
What this trial is testing

Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy

Who this might be right for
Chronic Hepatitis c
Hospices Civils de Lyon 103
Early research (Phase 1)Study completedNCT04470388
What this trial is testing

EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

Who this might be right for
Chronic HBV Infection
Enanta Pharmaceuticals, Inc 25
Testing effectiveness (Phase 2)Looking for participantsNCT04648280
What this trial is testing

Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

Who this might be right for
HIV Infections With Multi Drug Resistant Virus
PENTA Foundation 60
Testing effectiveness (Phase 2)Study completedNCT00120835
What this trial is testing

Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Early research (Phase 1)Study completedNCT00000760
What this trial is testing

Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Testing effectiveness (Phase 2)Study completedNCT03721510
What this trial is testing

A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults

Who this might be right for
HIV/AIDS
International AIDS Vaccine Initiative 19
Not applicableStudy completedNCT01945008
What this trial is testing

Observational Study in HCV Chronic Infection

Who this might be right for
Hepatitis C, Chronic
Istituto Superiore di Sanità 7,600
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation